Your browser doesn't support javascript.
loading
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.
Besse, B; Mazières, J; Ribassin-Majed, L; Barlesi, F; Bennouna, J; Gervais, R; Moreau, L; Berard, H; Debieuvre, D; Molinier, O; Moro-Sibilot, D; Souquet, P J; Jacquot, S; Petit, L; Lena, H; Pignon, J P; Lacas, B; Morin, F; Milleron, B; Zalcman, G; Soria, J C.
Afiliação
  • Besse B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France and Paris-Sud University, Orsay, France.
  • Mazières J; Thoracic Oncology, Hôpital Larrey, Centre Hospitalier Universitaire, Paul Sabatier University, Toulouse.
  • Ribassin-Majed L; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif.
  • Barlesi F; INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif.
  • Bennouna J; Multidisciplinary Oncology & Therapeutic Innovations Department, Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille.
  • Gervais R; Cancer, Institut de Cancérologie de l'Ouest, Nantes-Angers.
  • Moreau L; Department of Oncology, Centre François Baclesse, Caen.
  • Berard H; Pneumology, Hôpital Pasteur, Hôpitaux Civils de Colmar, Colmar.
  • Debieuvre D; Pneumology, Hôpital Inter Armées Sainte-Anne, Toulon.
  • Molinier O; Respiratory Disease Department, Emile Muller Hospital, GHRMSA, Mulhouse.
  • Moro-Sibilot D; Respiratory Medicine Department, Hospital, Avenue Rubillard, Le Mans.
  • Souquet PJ; Thoracic Oncology Unit, PTV, CHU Grenoble Alpes and INSERM U823, Grenoble.
  • Jacquot S; Pneumology, Hopital Lyon Sud, Pierre-Bénite.
  • Petit L; Department of Oncology, Centre de Cancérologie du Grand Montpellier, Montpellier.
  • Lena H; Department of Pulmonology, Centre Hospitalier Alpes Leman, Contamine sur Arve.
  • Pignon JP; Pneumology, Centre Hospitalier Universitaire, Rennes.
  • Lacas B; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif.
  • Morin F; INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif.
  • Milleron B; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif.
  • Zalcman G; INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif.
  • Soria JC; Intergroupe Francophone de Cancérologie Thoracique (IFCT), Paris.
Ann Oncol ; 28(5): 1078-1083, 2017 May 01.
Article em En | MEDLINE | ID: mdl-28327934
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Relação Dose-Resposta a Droga Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Relação Dose-Resposta a Droga Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França